材料科学
生物相容性
肌成纤维细胞
癌症研究
增生性瘢痕
谷胱甘肽
纤维化
放射治疗
药理学
医学
病理
外科
生物化学
酶
化学
冶金
作者
Bin Zhao,Wenfeng Guo,Xiaomeng Zhou,Yumeng Xue,Tianyi Wang,Qiang Li,Lili Tan,Shang Li
标识
DOI:10.1002/adfm.202300575
摘要
Abstract Hypertrophic scarring, an abnormal fibroproliferative wound‐healing disease, has brought tremendous burden for global healthcare systems. To date, no satisfactory treatment of hypertrophic scarring is available yet. Ferroptosis, an iron‐dependent form of cell death, has attracted much attention recently for the therapy of diseases featuring iron addiction. Intriguingly, myofibroblasts derived from hypertrophic scarring are found to exhibit a high iron state which appears to be sensitive to trigger ferroptosis for scarring treatment. Accordingly, in this study, a pH responsive self‐assembly nanoplatform is designed by encapsulating silver nanoclusters (AgNCs) and Chinese herbal medicine trigonelline (TRG) into zeolitic imidazolate framework‐8 (ZIF‐8) for synergistic ferroptosis therapy against hypertrophic scarring. The fabricated AgNC/TRG/ZIF‐8 composites exhibit good biocompatibility and pH responsive‐degradation inside myofibroblasts. The ZIF‐8 precursors can increase the generation of lipid reactive oxygen species and deplete intracellular glutathione (GSH). Also, AgNCs have the capability to consume GSH, while TRG can inhibit the activity of glutathione peroxidase. Consequently, the synergistic ferroptosis anti‐scarring therapy can be effectively achieved. Furthermore, AgNC/TRG/ZIF‐8‐loaded microneedle patches made of gelatin methacrylate show remarkable therapeutic effect against hypertrophic scarring on a rabbit ear model. This study suggests the great potential of ferroptosis‐mediated strategy for treating fibrotic skin diseases in future clinical application.
科研通智能强力驱动
Strongly Powered by AbleSci AI